Skip to main content
Iambic Therapeutics, Inc. (IAM)
NASDAQ: IAM · Real-Time Price · USD
15.39
+0.61 (4.09%)
At close: Nov 11, 2026, 4:00 PM EST
15.22
-0.16 (-1.06%)
Pre-market: Nov 12, 2026, 4:57 AM EST

Iambic Therapeutics Revenue

Iambic Therapeutics had revenue of $6.38M in the quarter ending June 30, 2026. This brings the company's total for the last twelve months to $18.25M. In the year 2025, Iambic Therapeutics had annual revenue of $9.43M with 689.45% growth. That makes Iambic Therapeutics the 34,379th largest company in the world by revenue and 4,512th in the United States.

Revenue (ttm)
$18.25M
Revenue Growth
+689.45%
P/S Ratio
39.96
Revenue / Employee
$106,731
Employees
171
Market Cap
729.26M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20259.43M8.23M689.45%
Dec 31, 20241.19M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

IAM News

More News